Carcinomatosis From Gastrointestinal Cancer
Paul H Sugarbaker
Published 2004 · Medicine
Download PDFAnalyze on Scholarcy
Gastrointestinal cancer has in the past been regarded as a lethal extension of the malignant process. Natural history studies have confirmed that this is so in the absence of special treatments. Recently, a combined treatment approach which utilizes cytoreductive surgery to remove all visible disease within the abdomen and pelvis followed by perioperative intraperitoneal chemotherapy has demonstrated success in phase II and phase III studies. The greatest benefit has been seen with appendiceal malignancy with cure rates approaching 80%. Also, colon cancer has been cured in approximately 30% of patients with complete removal of tumor by cytoreductive surgery. The morbidity and mortality of these procedures compares well with other gastrointestinal cancer operations. One may conclude that selected patients with carcinomatosis should expect long‐term survival with a combined treatment approach using cytoreductive surgery with perioperative intraperitoneal chemotherapy.
This paper references
Successful management of microscopic residual disease in large bowel cancer
Paul H Sugarbaker (1999)
Clinical Pathway for the Management of Resectable Gastric Cancer with Peritoneal Seeding: Best Palliation with a Ray of Hope for Cure
Paul H Sugarbaker (2000)
Paul H Sugarbaker (2003)
Perioperative intraperitoneal chemotherapy in resectable gastric cancer: Surgical responsibilities
P H Sugarbaker
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy
Paul H Sugarbaker (1999)
Pseudomyxoma Peritonei Long‐Term Patient Survival with an Aggressive Regional Approach
David B. Gough (1994)
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study.
B Sadeghi (2000)
Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
Richard P. McQuellon (2001)
Peritoneal Carcinomatosis: Principles of Management
Paul H Sugarbaker (1996)
Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology.
Paul H Sugarbaker (1996)
Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection.
Yasuhiro Kodera (1999)
Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum.
Akeo Hagiwara (1998)
Heated Intraoperative Intraperitoneal Mitomycin C and Early Postoperative Intraperitoneal 5-Fluorouracil: Pharmacokinetic Studies
Pierre Jacquet (1998)
Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid.
M. A. Meyers (1973)
Hyperthermic intra peritoneal chemotherapy (HIPEC) with mitomycin C signi®cantly improves survival in patients with peritoneal carcinomatosis of colorectal origin
Initiation of a program in peritoneal surface malignancy.
Luis González Bayón (2003)
Modelstudies over het colorectale carcinoom
Fan Zoetmulder (1982)
Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Arjen J Witkamp (2001)
Pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis has a signi®cantly more favorable prognosis than peritoneal mucinous carcinomatosis
B M Ronnett (2001)
Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models.
Reyer T. Ottow (1987)
Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique
Arvil D. Stephens (1999)
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment.
B. Berthet (1999)
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
Perry Shen (2003)
Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience.
Paul H Sugarbaker (2002)
Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer
P H Sugarbaker (1990)
Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized Trial
Wansik Yu (2001)
Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy
Paul H Sugarbaker (1995)
Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors.
David Z. J. Chu (1989)
Editorial) Carcinomatosis, is cure an option?
P H Sugarbaker (2003)
Second-look Surgery after Cytoreduction and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer: Analysis of Prognostic Features
Alberto Gómez Portilla (1999)
Peritoneal carcinomatosis from colorectal cancer.
D. G. Jayne (2002)
THE SPREAD OF INTRAPERITONEAL INFECTION. STUDIES WITH ROENTGEN CONTRAST MEDIUM.
V Autio (1964)
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.
Dominique M Elias (2001)
Metastatic inef®ciency: Causes and consequences
L Weiss (1986)
Implantation Peritoneal Carcinomatosis of Ovarian Origin.
John A. Sampson (1931)
Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread
C. Pablo Carmignani (2004)
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery.
Pierre Jacquet (1995)
This paper is referenced by
Surgery for Peritoneal Carcinomatosis from Colorectal Origin: Techniques and Limitations
Wim P Ceelen (2006)
Survival of patients with pseudomyxoma peritonei treated by serial debulking.
Petrus Järvinen (2010)
New approach to peritoneal surface malignancies.
Antonio Macrì (2010)
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
W. J. van Eden (2017)
Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei.
Pirjo Nummela (2016)
Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei
Petrus Järvinen (2017)
Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study
Marianne Maillet (2015)
Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin
Petrus Järvinen (2014)
The Effect of Perineural Invasion on Overall Survival in Patients with Gastric Carcinoma
Luo Tian-hang (2008)
Feasibility of Radical Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy For Pseudomyxoma Peritonei of Appendiceal Origin
Petrus Järvinen (2013)
Clinical Presentation of Pseudomyxoma Peritonei
Petrus Järvinen (2010)
Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection
Ahmet Erkan Bilici (2010)
Perforation Due to Colon Cancer: Predisposing Factors and Clinical Presentation Kolonik Tümör Perforasyonu: Predispozan Faktörler, Klinik Bulgu ve Semptomlar
Abdullah Bahadır Öz (2013)
Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia.
Antonio Macrì (2011)